🚫Oh, look! Goldman Sachs is pondering if curing diseases is just too *profitable* for capitalism's taste. 🤑 Unfortunately, the depth of this groundbreaking revelation remains locked behind a 403 barrier. 🙈🔒
https://www.cnbc.com/2018/04/11/goldman-asks-is-curing-patients-a-sustainable-business-model.html #GoldmanSachs #CuringDiseases #Capitalism #Profitability #HealthcareEthics #403Error #HackerNews #ngated
Goldman Sachs asks in biotech research report: 'Is curing patients a sustainable business model?'

Goldman Sachs warns sales from the most successful disease treatments are difficult to maintain.

CNBC
Could CRISPR gene therapy help treat Alzheimer's disease?

Scientists have found approaches to reduce the impact of both the strongest genetic risk factor for Alzheimer's and the production of beta-amyloid.

Medical News Today